A single-atom nanozyme mimicking cytochrome c oxidase restores mitochondrial energy production in stem cells, shifting their ...

Medical oncologist (ex AstraZeneca, MorphoSys, Autolus Therapeutics) joins to advance Asgard’s lead asset AT-108 into Phase 1 ...

Some jellyfish possess the extraordinary ability to revert their cells back to an earlier developmental stage, effectively ...

From billionaire-backed biotech to promising animal studies, this early trial will test whether partial reprogramming can ...

A burgeoning field is launching its first clinical trial to find out whether dialing back cell development can safely refresh ...

Researchers at Oregon Health & Science University have uncovered a key reason why immunotherapy has largely failed in ...

Scientists at Life Biosciences are preparing to begin testing partial reprogramming in people. It will mark the first time ...

Portland scientists at Oregon Health & Science University say they have figured out why pancreatic tumors so often brush off ...

Researchers at Oregon Health & Science University have uncovered a key reason why immunotherapy has largely failed in ...

Cancer biology research increasingly recognizes the profound heterogeneity and plasticity of cancer cells. These cells can transition dynamically between ...

Researchers at Oregon Health & Science University have uncovered a key reason why immunotherapy has largely failed in ...

Life Biosciences, a Boston longevity biotech co-founded by Harvard genetics professor David Sinclair, has locked down an $80 ...